代谢综合征与腹腔镜肾上腺切除术后并发症及医疗资源使用增加相关
该研究基于美国外科医师学会国家外科质量改进计划数据库2005至2014年3502例择期腹腔镜肾上腺切除术患者,其中395例(11.3%)合并代谢综合征。多变量分析显示代谢综合征是总体死亡/并发症、主要并发症、肺部并发症、输血需求和延长住院的独立预测因素。
要点
- 代谢综合征是腹腔镜肾上腺切除术后总体死亡/并发症的独立预测因素(OR 1.86)。
- 代谢综合征与输血风险约2倍及住院延长几率增加34%相关。
- 术前识别代谢综合征有助于风险评估与资源规划。
核心结论
- 代谢综合征增加腹腔镜肾上腺切除术后并发症风险,并与输血风险约2倍及住院延长几率增加34%相关。
研究设计与样本
- 基于美国外科医师学会国家外科质量改进计划数据库2005至2014年的回顾性队列研究,共纳入3502例择期腹腔镜肾上腺切除术患者。
- 代谢综合征定义为体重指数≥30 kg/m2且合并需药物治疗的糖尿病和高血压。
- 采用单变量和多变量分析评估30天死亡/并发症、主要并发症及医疗资源使用情况。
主要发现
- 395例(11.3%)患者合并代谢综合征,其年龄更大(P < .001)且术前合并症比例更高(P < .05)。
- 未调整分析中,代谢综合征与死亡/并发症、主要并发症、住院时间、手术时间和输血风险增加相关(均P < .001)。
- 多变量分析中,代谢综合征是总体死亡/并发症(OR 1.86;P < .001)、主要并发症(OR 1.99;P < .001)、肺部并发症(OR 1.83;P = .049)、输血需求(OR 1.94;P = .04)和延长住院(OR 1.34;P = .02)的独立预测因素。
临床怎么用
- 对拟行腹腔镜肾上腺切除术的患者术前评估代谢综合征,以识别并发症和资源使用风险较高者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rates of obesity and metabolic syndrome continue to rise worldwide; however, the impact of metabolic syndrome on outcomes following adrenalectomy has not been described. In this study, we sought to investigate the effects of metabolic syndrome on postoperative 30-day morbidity, mortality, and utilization of hospital resources in a large cohort of patients undergoing elective laparoscopic adrenalectomy. METHODS: Patients who underwent laparoscopic adrenalectomy from 2005 to 2014 were identified in the American College of Surgeons National Surgical Quality Improvement Program database. Patients with body mass index ≥30 kg/m2 who also had diabetes and hypertension requiring medications were defined as having metabolic syndrome. Univariate and multivariable analyses were performed for the outcomes of 30-day mortality/morbidity, major complications, and utilization of hospital resources (prolonged duration of stay ≥3 days and requirement for perioperative blood transfusion). RESULTS: Of the 3,502 patients included in the study, 395 had metabolic syndrome (11.3%). Patients with metabolic syndrome were older (P < .001) and had a greater percentage of preoperative comorbidities (P < .05) than patients without metabolic syndrome. On unadjusted analysis, metabolic syndrome was associated with an increased risk for mortality/morbidity, major complications, duration of stay, operative time, and risk for blood transfusion (all P < .001). On multivariable analysis, metabolic syndrome was an independent predictor of overall mortality/morbidity (odds ratio, 1.86; P < .001), major complications (odds ratio, 1.99; P < .001), pulmonary complications (odds ratio, 1.83; P = .049), the need for blood transfusion (odds ratio, 1.94; P = .04), and prolonged length of stay (odds ratio odds ratio, 1.34; P = .02). CONCLUSION: The presence of metabolic syndrome increased the risk for postoperative complications after laparoscopic adrenalectomy and was associated with 2-fold risk for blood transfusion and 34% increased odds of a prolonged hospital stay.
引用
- Shariq OA, Fruth KM, Hanson KT, et al. Metabolic syndrome is associated with increased postoperative complications and use of hospital resources in patients undergoing laparoscopic adrenalectomy. Surgery. 2017. PMID: 29108705. doi:10.1016/j.surg.2017.06.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。